150 related articles for article (PubMed ID: 11647207)
21. Conflict of interest highlighted in debate on calcium-channel blockers.
McCarthy M
Lancet; 1998 Jan; 351(9097):191. PubMed ID: 11656736
[No Abstract] [Full Text] [Related]
22. A duty to publish.
Nat Med; 1998 Oct; 4(10):1089. PubMed ID: 9771720
[No Abstract] [Full Text] [Related]
23. Dialogue: disclosure of conflicts of interest--edited excerpts from two seminars.
Relman AS
Sci Technol Human Values; 1985; 10(2):36-40. PubMed ID: 11649679
[No Abstract] [Full Text] [Related]
24. Conflicts of interest.
Nature; 1989 Aug; 340(6236):664. PubMed ID: 11644385
[No Abstract] [Full Text] [Related]
25. Conflict or synergy: university-industry research relations.
Schmitt RW
Account Res; 1997; 5(4):251-4. PubMed ID: 11656991
[No Abstract] [Full Text] [Related]
26. Non-starters and no brainers: an outside perspective.
David EE
Account Res; 1997; 5(4):255-63. PubMed ID: 11656992
[No Abstract] [Full Text] [Related]
27. Can academia adapt to biotechnology's lure?
Fox JL
Chem Eng News; 1981 Oct; 59(41):39-44. PubMed ID: 11650512
[No Abstract] [Full Text] [Related]
28. The toxicity/safety of processed free glutamic acid (MSG): a study in suppression of information.
Samuels A
Account Res; 1999; 6(4):259-310. PubMed ID: 11657840
[No Abstract] [Full Text] [Related]
29. Professors minding their own business.
Murray M
Sci News; 1986 Jun; 129(24):374. PubMed ID: 11653719
[No Abstract] [Full Text] [Related]
30. Criminal liability for misconduct in scientific research.
Kuzma SM
Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
[No Abstract] [Full Text] [Related]
31. Research suppressed for seven years by drug company.
Wise J
BMJ; 1997 Apr; 314(7088):1145. PubMed ID: 9146378
[No Abstract] [Full Text] [Related]
32. Drug trials hide conflicts for doctors.
Eichenwald K; Kolata G
N Y Times Web; 1999 May; ():1, 34. PubMed ID: 11648114
[No Abstract] [Full Text] [Related]
33. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986.
Bulleit TN
J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568
[No Abstract] [Full Text] [Related]
34. A prostate researcher tested firm's product -- and sat on its board.
Burton TM
Wall St J (East Ed); 1998 Mar; ():A1, A8. PubMed ID: 11648093
[No Abstract] [Full Text] [Related]
35. University-industry relationships in genetic research: potential opportunities and pitfalls.
Walsh ME; Graber GC; Wolfe AK
Account Res; 1997; 5(4):265-82. PubMed ID: 11656993
[No Abstract] [Full Text] [Related]
36. Biotechnology and the social reconstruction of molecular biology.
Markle GE; Robin SS
Sci Technol Human Values; 1985; 10(1):70-9. PubMed ID: 11650692
[No Abstract] [Full Text] [Related]
37. Commentary: biology faces life--pressures on communications and careers.
Holtzman E
Sci Technol Human Values; 1985; 10(2):64-72. PubMed ID: 11649682
[No Abstract] [Full Text] [Related]
38. Why I oppose drug company payment of physician/investigators on a per patient/subject basis.
Roizen R
IRB; 1988; 10(1):9-10. PubMed ID: 11658990
[No Abstract] [Full Text] [Related]
39. Sharing scientific data III: planning and the research proposal.
Flournoy N; Hearne LB
IRB; 1990; 12(3):6-9. PubMed ID: 11651388
[No Abstract] [Full Text] [Related]
40. The case for per patient payments.
Lewis JP
IRB; 1988; 10(5):9. PubMed ID: 11650075
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
